Lyndra® Therapeutics

As of March 26, 2025, Lyndra Therapeutics has ceased operations.

Please direct any inquiries by email to Craig Jalbert at [email protected].

[Lyndra® Therapeutics @LyndraInc]

We’re honored to announce the close of a $101 Million Series E funding round, led by Sarissa Capital and including Sun Pharma and Polaris Partners, to support the development of therapies with our LYNXTM drug delivery platform. https://t.co/irBj9HXuhu

[Lyndra® Therapeutics @LyndraInc]

Lyndra has announced leadership changes and an update on pivotal trial progress! Learn more about the announcement in our press release: https://t.co/u1EEzxpkjp

[HCPLive @HCPLiveNews]

A new trial testing risperidone (LYN-005) as a weekly oral treatment for patients with #schizophrenia has officially begun.

https://t.co/43MNhkP9oA

[Healio Psychiatry @HealioPsych]

.@LyndraInc began dosing in a clinical trial of risperidone for #schizophrenia and #schizoaffective and #bipolar disorders. The drug would introduce a long-acting oral option to schizophrenia treatment. https://t.co/OAeTQKPFLn

[Lyndra® Therapeutics @LyndraInc]

Today Lyndra announced the dosing of the first participant in our pivotal trial evaluating oral weekly risperidone (LYN-005) in adults with schizophrenia or schizoaffective disorder.

Read more here: https://t.co/jtnlHrEAJj

#Lynx #Innovation #Biotech

[Lyndra® Therapeutics @LyndraInc]

Learn more here: https://t.co/VsJakK77wN
#WomanCEO

[Lyndra® Therapeutics @LyndraInc]

Our CEO @TrishHurter is joining @MIT's 4th Symposium of the International Consortium for Advanced Medicines Manufacturing (ICAMM), in Cambridge, MA from April 27-28.
Her talk, “Celebrating Success: Advanced #Manufacturing of Small Molecules,” starts at 10:00 AM EST tomorrow.

[Lyndra® Therapeutics @LyndraInc]

Many Lyndra team members bring a personal passion to their work, including our CEO @TrishHurter. In recognition of the @WHO's #WorldMalariaDay today, read Trish’s personal story of her commitment to malaria eradication & how it inspires her work at Lyndra: https://t.co/OVzqPS1NyD

[Lyndra® Therapeutics @LyndraInc]

She’ll be talking about the initiation of our pivotal trial for oral weekly risperidone (LYN-005), a long-acting oral pill being evaluated for the treatment of schizophrenia or schizoaffective disorder. Learn more here: https://t.co/9kuhEm39dT

[Lyndra® Therapeutics @LyndraInc]

Our President and Chief Operations Officer @JBallLyndra will be joining the @WatertownBiz annual Life Science panel on April 25 at 5:30 PM EST, at the Mosesian Center.
#Watertown #LifeSciences

[Lyndra® Therapeutics @LyndraInc]

We look forward to a world where long-acting oral therapies can help to better “achieve health for all.”

Read more about the #LYNX drug delivery platform, designed to deliver long-acting oral therapies here: https://t.co/44EH8a1Hdb

[Lyndra® Therapeutics @LyndraInc]

This year’s #WorldHealthDay’s theme of #HealthForAll is close to our hearts, given our efforts to improve how oral medicines are delivered, starting with serious mental health conditions like schizophrenia.

#WHO75

[Lyndra® Therapeutics @LyndraInc]

@WHO notes that schizophrenia affects ~24 million people worldwide. Despite effective treatment options, medication adherence is a struggle for many.

[Lyndra® Therapeutics @LyndraInc]

Spring has sprung! We’re celebrating new opportunities as we head into the warmer months in Boston. The season represents rebirth & rejuvenation, carrying an important weight for many cultures.

We’re wishing a Happy Easter, Happy Passover & Ramadan Mubarak to those who celebrate

[Lyndra® Therapeutics @LyndraInc]

Our President & COO @JballLyndra is speaking at @HarvardGSAS Biotech Club’s distinguished speaker series today, April 6. She will share her career journey & work since joining Lyndra to finance, build partnerships, manage operations & her advice for the next generation in #STEM

[Lyndra® Therapeutics @LyndraInc]

According to @NAMIcommunicate, around 7 million people in the U.S. live with bipolar disorder. @WorldBipolarDay aims to address stigma through education; we recommend a recent blog from NAMI titled "Understanding Bipolar Disorder":

https://t.co/3NvcwnIT29

[Lyndra® Therapeutics @LyndraInc]

In honor of #WomensHistoryMonth, we’re sharing this quote from our President and Chief Operations Officer @JBallLyndra on her path to success from @ISPEOrg’s Facilities of the Future Conference.

Check out quotes from Jess and other panelists: https://t.co/IscGZBjUpx

#IWD2023

[Lyndra® Therapeutics @LyndraInc]

Register for the event here: https://t.co/Mx179emOrw

[Lyndra® Therapeutics @LyndraInc]

Our director of R&D Ops and Risk Management Divya Krishnamurthy, Ph.D., is a featured speaker at the #LabFacilitiesSummit in Boston. Her March 23 roundtable will cover health and safety guidelines, emergency action, waste disposal and recycling.

[Lyndra® Therapeutics @LyndraInc]

What makes #Lyndra’s approach to oral drug delivery unique? Our Chief Medical Officer Richard Scranton, MD, MPH, speaks about how, as part of our core purpose to reinvent medicine for a healthier world, we’re aiming to fundamentally change how pills work.

#Adherence